| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. (APLS) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. APLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.18M | $48.30M | - | |
| CEO | 482.0K | $19.78M | - | |
| Dir | 385.0K | $15.80M | - | |
| Dir | 161.6K | $6.63M | - | |
| CFO | 152.0K | $6.24M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | Eisele Jeffrey76 | Chief Development Officer | Sell | 63 | $33.09 | $2,084.67 | -0.1% | -26.9% | -25.3% | |
| Dec 11, 2024 | Watson David O.70 | General Counsel | Sell | 5,000 | $34.24 | $171,175.00 | -4.2% | -24.9% | -26.6% | |
| Sep 16, 2024 | Dunlop A. Sinclair62 | Director | Sell | 37,000 | $36.23 | $1,340,596.80 | -15.1% | -7.3% | -34.4% | |
| Sep 16, 2024 | Chopas James George80 | Vp/ Chief Accounting Officer | Sell | 192 | $36.21 | $6,951.55 | -0.5% | -7.3% | -34.4% | |
| Sep 3, 2024 | Chopas James George80 | Vp/ Chief Accounting Officer | Sell | 550 | $39.49 | $21,720.05 | -1.4% | -8.7% | -28.4% | |
| Jun 21, 2024 | Dunlop A. Sinclair62 | Director | Sell | 37,000 | $39.24 | $1,451,834.95 | -11.8% | -3.5% | -53.5% | |
| May 8, 2024 | Deschatelets Pascal69 | Chief Scientific Officer | Sale+OE | 78,907 | $42.35 | $3,341,848.01 | -2.3% | -17.0% | -57.9% | |
| Apr 8, 2024 | Deschatelets Pascal69 | Chief Scientific Officer | Sale+OE | 69,107 | $54.17 | $3,743,605.22 | -3.0% | -31.2% | -65.2% | |
| Apr 1, 2024 | Sullivan Timothy Eugene85 | Chief Financial Officer | Sale+OE | 4,000 | $58.66 | $234,640.00 | -4.1% | -39.2% | -62.0% | |
| Mar 19, 2024 | Dunlop A. Sinclair62 | Director | Sell | 18,681 | $57.18 | $1,068,160.90 | -9.7% | -29.1% | -56.4% |